Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer
Conditions: Pancreatic Cancer; Metastatic Pancreatic Cancer Intervention: Drug: nab paclitaxel plus gemcitabine Sponsors: Asan Medical Center; Bundang CHA Hospital; Ulsan University Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials